Related Experiment Video

Updated: Jul 19, 2026

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model
12:49

Porcine Liver Transplantation Without Veno-Venous Bypass As an Extended Criteria Donor Model

Published on: August 17, 2022

The status of liver transplantation for hepatitis C

Andrew M Cameron1, Ronald W Busuttil

  • 1Dumont-UCLA Liver Transplant Center, David Geffen School of Medicine at UCLA, Department of Surgery, 10833 LeConte Ave, 77-132 CHS, Los Angeles, CA 90095, USA. acameron@mednet.ucla.edu

Expert Opinion on Biological Therapy
|September 23, 2006
PubMed

Insights

Hepatitis C virus (HCV) infection affects 170 million globally, often leading to chronic disease and liver failure. Orthotopic liver transplantation (OLT) offers hope but faces challenges like organ scarcity and graft reinfection.

Area of Science:

  • Hepatology
  • Virology
  • Transplantation Immunology

Background:

  • Hepatitis C virus (HCV) infection impacts approximately 170 million individuals worldwide, representing 3% of the global population.
  • The majority of acute HCV infections progress to chronic states, frequently becoming resistant to current antiviral therapies.
  • Chronic HCV infection over two decades can result in severe liver conditions such as cirrhosis and its complications, including hepatic encephalopathy, ascites, variceal hemorrhage, and hepatocellular carcinoma.

Purpose of the Study:

  • To review the outcomes of Orthotopic Liver Transplantation (OLT) for Hepatitis C virus (HCV) patients at the Dumont-UCLA Liver Transplant Center.
  • To explore future strategies for managing HCV in the context of liver transplantation.

Main Methods:

  • Review of clinical data and outcomes from OLT procedures for HCV patients at a specific transplant center.
  • Analysis of existing literature and trends in HCV management and liver transplantation.

Main Results:

  • Orthotopic liver transplantation (OLT) is identified as the primary treatment for end-stage liver disease caused by HCV cirrhosis.
  • Significant challenges persist, including limited donor organ availability and the high incidence of graft reinfection post-transplantation.
  • The review presents results from the Dumont-UCLA Liver Transplant Center, offering insights into the efficacy and limitations of OLT for HCV.

Conclusions:

  • Orthotopic liver transplantation (OLT) remains a critical intervention for advanced HCV-related liver disease.
  • Addressing organ donor shortages and preventing graft reinfection are paramount for improving long-term outcomes in HCV patients undergoing OLT.
  • Future research and clinical strategies should focus on optimizing OLT and developing novel approaches for HCV management.

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...